IP Library › Assignment 024424/0724
Patent Assignment
Reel/Frame 024424/0724

Change of Name

Recorded: 2010-05-24 Pages: 10
Assignor
SCHWARZ PHARMA AG
Executed: 2010-01-20
Assignee
UCB PHARMA GMBH
ALFRED-NOBEL-STRASSE 10, MONHEIM, 40789, GERMANY
Covered Properties (15)
Novel Derivatives of 3,3-Diphenylpropylamines
Patent: 6,713,464 →
Application: 09/700,094 →
Stable Salts of Novel Derivatives of 3,3-Diphenylpropylamines
Patent: 6,858,650 →
Application: 10/130,214 →
Shortened Synthesis of 3,3-Diarylpropylamine Derivatives
Patent: 6,809,214 →
Application: 10/297,778 →
Publication: US 2003/0212292
Method for Producing 3,3-Diarylpropylamines
Patent: 6,809,225 →
Application: 10/332,290 →
Publication: US 2004/0034080
Device for transdermal administration for the treatment of urinary tract disorders
Application: 10/497,199 →
Publication: US 2005/0226919
Highly pure bases of 3,3-dipheyl propylamine monoesters
Application: 10/532,836 →
Publication: US 2006/0014832
Transdermal Administration of (R)-3,3-Diphenylpropylamin-Monoesters
Patent: 7,670,621 →
Application: 10/533,683 →
Publication: US 2006/0029673
Novel Derivatives of 3,3-Diphenylpropylamines
Patent: 7,230,030 →
Application: 10/766,263 →
Publication: US 2004/0186061
Novel Derivatives of 3,3-Diphenylpropylamines
Patent: 7,384,980 →
Application: 11/201,756 →
Publication: US 2006/0270738
Pharmaceutical Compositions Comprising Fesoterodine
Patent: 7,807,715 →
Application: 11/811,327 →
Publication: US 2008/0138421
High Purity Bases of 3,3-Diphenylpropylamino Monoesters
Patent: 7,989,654 →
Application: 12/141,489 →
Publication: US 2009/0012159
Chiral Intermediate, Process for Producing the Same and Its Use in the Manufacture of Tolterodine, Fesoterodine, or the Active Metabolite Thereof
Patent: 7,982,058 →
Application: 12/304,323 →
Publication: US 2009/0192224
Pharmaceutical Compositions Comprising Fesoterodine
Patent: 8,088,398 →
Application: 12/342,744 →
Publication: US 2009/0117159
Transdermal Delivery of (R)-3,3-Diphenylpropylamin-Monoestern
Patent: 7,919,117 →
Application: 12/417,405 →
Publication: US 2009/0274761
Pharmaceutical Compositions Comprising Fesoterodine
Patent: 8,501,723 →
Application: 12/692,063 →
Publication: US 2010/0130606
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 2001
From: MEESE, CLAUS; SPARF, BENGT
To: SCHWARZ PHARMA AG
Reel/Frame 011443/0478 →
Assignment of Assignor's Interest May 14, 2002
From: MEESE, CLAUS
To: SCHWARZ PHARMA AG
Reel/Frame 013122/0883 →
Assignment of Assignor's Interest Dec 9, 2002
From: MEES, CLAUS
To: SCHWARZ PHARMA AG
Reel/Frame 014088/0186 →
Assignment of Assignor's Interest Jul 14, 2003
From: DONSBACH, MARTIN; EILBRACHT, PETER; BUSS, CHRISTIAN; SCHMIDT, ANDREAS
To: SCHWARZ PHARMA AG
Reel/Frame 014471/0376 →
Corrective Coversheet to Correct the Name of the Assignor and Assignee That Was Previously Recorded on Reel 014088, Frame 0186. Nov 28, 2003
From: MEESE, CLAUS
To: SCHWARZ PHARMA AG
Reel/Frame 014746/0086 →
Assignment of Assignor's Interest Apr 26, 2005
From: BREITENBACH, ARMIN; MEESE, CLAUS; WOLFF, HANS-MICHAEL; DREWS, ROLAND
To: SCHWARZ PHARMA AG
Reel/Frame 017106/0507 →
Assignment of Assignor's Interest Apr 26, 2005
From: BREITENBACH, ARMIN; MEESE, CLAUS; WOLFF, HANS-MICHAEL; DREWS, ROLAND
To: SCHWARZ PHARMA AG
Reel/Frame 017102/0534 →
Confirmation of Exclusive Patent License Feb 20, 2007
From: SCHWARZ PHARMA AG; SCHWARZ PHARMA LIMITED
To: PFIZER INC.
Reel/Frame 018942/0916 →
Assignment of Assignor's Interest Jun 29, 2007
From: DRESSEN, FRANK; SCHACHT, DIETRICH; WOLFF, HANS-MICHAEL
To: SCHWARZ PHARMA AG
Reel/Frame 019522/0316 →
Assignment of Assignor's Interest Feb 21, 2008
From: MIKA, JANS-JURGEN; ARTH, CHRISTOPH; KOMENDA, MICHAEL; BICANE, FATIMA
To: SCHWARZ PHARMA AG
Reel/Frame 020594/0792 →
Assignment of Assignor's Interest Jan 7, 2009
From: MEESE, CLAUS
To: SCHWARZ PHARMA AG
Reel/Frame 022072/0813 →